RA Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130M | Buy |
9,902,633
+993,542
| +11% | +$13M | 2.19% | 12 |
|
|
2025
Q1 | $196M | Hold |
8,909,091
| – | – | 3.27% | 7 |
|
|
2024
Q4 | $238M | Hold |
8,909,091
| – | – | 3.17% | 6 |
|
|
2024
Q3 | $238M | Hold |
8,909,091
| – | – | 2.74% | 9 |
|
|
2024
Q2 | $160M | Hold |
8,909,091
| – | – | 2.12% | 15 |
|
|
2024
Q1 | $163M | Buy |
+8,909,091
| New | +$163M | 2.07% | 11 |
|
|
2022
Q2 | – | Sell |
-2,613,623
| Closed | -$25.4M | – | 92 |
|
|
2022
Q1 | $25.4M | Hold |
2,613,623
| – | – | 0.55% | 51 |
|
|
2021
Q4 | $39.9M | Hold |
2,613,623
| – | – | 0.7% | 42 |
|
|
2021
Q3 | $43.4M | Hold |
2,613,623
| – | – | 0.6% | 43 |
|
|
2021
Q2 | $55.7M | Hold |
2,613,623
| – | – | 0.89% | 35 |
|
|
2021
Q1 | $84.9M | Buy |
+2,613,623
| New | +$84.9M | 1.28% | 22 |
|